Trial intelligence / Profile preview

Pharmacokinetics and dynamics of intrathecal baclofen therapy in patients with spasticity

2008-004934-26Phase 4Active

Sponsor
University Medical Center Groningen
Start
Nov 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of baclofen in Muscle spasm and multiple sclerosis (MS), sponsored by University Medical Center Groningen. Primary endpoint: Tolerance to intrathecal baclofen therapy. Started Nov 2008; status: active.

02

Drugs

baclofen
03

Conditions

Muscle spasmmultiple sclerosis (MS)

Beyond the preview

Go deeper on 2008-004934-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004934-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call